Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Myelogenous Leukemia, Adult”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT06297772
What this trial is testing

Compare the Efficacy and Safety of Dec-FB4 and FB4 as Conditioning Regimen for AML-MR

Who this might be right for
AML, Adult
Ruijin Hospital 220
Early research (Phase 1)Ended earlyNCT05607199
What this trial is testing

A First in Human Study of AUR 103 Calcium to Evaluate Safety, Pharmacokinetics and Pharmacodynamics

Who this might be right for
Solid Tumor, AdultAcute Myeloid LeukemiaMyelodysplastic Syndromes+1 more
Aurigene Discovery Technologies Limited 27
Testing effectiveness (Phase 2)Study completedNCT00416598
What this trial is testing

Decitabine as Maintenance Therapy After Standard Therapy in Treating Patients With Previously Untreated Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaAcute Myeloid Leukemia With Myelodysplasia-Related ChangesAdult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11+4 more
National Cancer Institute (NCI) 546
Not applicableStudy completedNCT01608204
What this trial is testing

Busulfan Pharmacokinetic Analysis and GST Pharmacogenetic Profile in Adults Undergoing Hematological Stem Cell Transplantation

Who this might be right for
Acute Myeloid Leukemia
Rambam Health Care Campus 63
Early research (Phase 1)Study completedNCT03393611
What this trial is testing

CPX-351 Salvage Therapy Followed by Haplo-Cord Transplant for Relapsed/Refractory Leukemia or Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic SyndromesLeukemia, Myeloid, AcuteLeukemia, Relapsed Adult Acute Myeloid+1 more
Weill Medical College of Cornell University 14
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06954987
What this trial is testing

Venetoclax or Placebo in Combination With Reduced-Intensity Conditioning Hematopoietic Cell (Bone Marrow/Blood Stem Cell) Transplant and as Maintenance Therapy After Transplant in Patients With Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)

Who this might be right for
Acute Myeloid Leukemia
National Cancer Institute (NCI) 244
Large-scale testing (Phase 3)UnknownNCT01633099
What this trial is testing

Therapeutic Effect and Safety Study of Decitabine in Elderly Acute Myeloid Leukemia Patients

Who this might be right for
Untreated Adult Acute Myeloid LeukemiaEffect of DrugsDrug Safety
Jianxiang Wang 46
Testing effectiveness (Phase 2)Study completedNCT01083706
What this trial is testing

Azacitidine in Treating Patients With Relapsed Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia Who Have Undergone Stem Cell Transplant

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+9 more
Fred Hutchinson Cancer Center 43
Testing effectiveness (Phase 2)WithdrawnNCT06586099
What this trial is testing

Tislelizumab with Azacitidine in the Treatment of R/R AML

Who this might be right for
Refractory AMLRelapsed Adult AML
Institute of Hematology & Blood Diseases Hospital, China
Testing effectiveness (Phase 2)Active Not RecruitingNCT03971799
What this trial is testing

Study of Anti-CD33 Chimeric Antigen Receptor-Expressing T Cells (CD33CART) in Children and Young Adults With Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myelogenous Leukemia
Center for International Blood and Marrow Transplant Research 52
Not applicableStudy completedNCT00049465
What this trial is testing

Standard Follow-up Compared With Extended Follow-up in Treating Patients Who Have Undergone Stem Cell Transplantation for Cancer

Who this might be right for
Cancer
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00089011
What this trial is testing

Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+171 more
Fred Hutchinson Cancer Center 150
Large-scale testing (Phase 3)Looking for participantsNCT05429632
What this trial is testing

Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

Who this might be right for
Adult Acute Myeloid Leukemia
Priothera SAS 366
Early research (Phase 1)Ended earlyNCT02049801
What this trial is testing

MEK Inhibitor MEK162, Idarubicin, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Adult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia (M5a)Adult Acute Monocytic Leukemia (M5b)+12 more
Bruno C. Medeiros 1
Early research (Phase 1)Study completedNCT00351975
What this trial is testing

Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases

Who this might be right for
Accelerated Phase of DiseaseAdult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11+17 more
National Cancer Institute (NCI) 56
Testing effectiveness (Phase 2)WithdrawnNCT04100330
What this trial is testing

Ficlatuzumab With HiDAC and HiDAC Alone in Adults With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
AVEO Pharmaceuticals, Inc.
Not applicableStudy completedNCT01005277
What this trial is testing

Study of Biomarkers in DNA Samples From Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia

Who this might be right for
Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11Adult Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1Adult Acute Promyelocytic Leukemia With PML-RARA+6 more
Children's Oncology Group 2,000
Not applicableStudy completedNCT05972577
What this trial is testing

Geriatric Optimization Plan to Improve Survival in Older Adult Allogeneic Hematopoietic Cell Transplant Candidates, OTIS Study

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAplastic Anemia+9 more
Ohio State University Comprehensive Cancer Center 30
Not applicableStudy completedNCT02844257
What this trial is testing

Transfusion Dependency at Diagnosis and Transfusion Intensity During Initial Chemotherapy Are Associated With Poorer Outcomes in Adult Acute Myeloid Leukaemia

Who this might be right for
Acute Myeloid Leukaemia
Hospices Civils de Lyon 1,067
Not applicableStudy completedNCT01290107
What this trial is testing

Biomarkers in Samples of Bone Marrow From Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
Children's Oncology Group 9
Next Page